Stay Updated with the Latest Apellis Pharmaceuticals, Inc. APLS News in Real Time
Find APLS news now at Meyka AI. Stay informed with the latest Apellis Pharmaceuticals, Inc. stocks updates, including price news, market analysis, and expert insights.
Meta Jumps 6% to $669 on AI Cloud Business and Strong Cash Flow
Meta stock rallies 6% to $669.21 on July 11, 2026, driven by AI cloud monetization strategy and $64.5B annual free cash flow. Meyka rates META a B with neutral outlook.
AstraZeneca Shares Plunge 7.4% After Heart Drug Trial Fails—July 10
AstraZeneca stock fell 7.4% after Wainua heart drug trial missed primary goal. Jefferies models $2.5B sales loss. Meyka grades AZN B+, forecasts $131.71 by year-end.
Blue Jet Healthcare (NSE: BLUEJET) Surges 8.5% After Raising ₹800 Crore Through QIP at ₹506 Per Share
Blue Jet Healthcare shares jumped as much as 8.5% on July 10, 2026. The rally followed the company’s ₹800 crore fundraise through a Qualified Institutional Placement. Blue Jet Healthcare allotted 15,810,276 equity shares at ₹506 each, a discount to the floor price. The QIP window ran from July 6 to July 9, 2026, before the…
Apple Inc. Stock Up 0.90% After Broadcom Supply Deal as Hedgeye Predicts 23% Downside
Apple Inc. shares rose 0.90% to around $316.21 on July 10, 2026. The gain follows a new $30 billion supply agreement with Broadcom announced July 8. Apple Inc. stock now trades near its 52-week high of $317.40. Yet Hedgeye issued a short call on July 9, forecasting a possible 23% decline. The mixed signals leave…
Google Play Store Faces Major UK Court Twist Ahead of £1 Billion Trial
Google’s Play Store is heading into an 11-week UK trial this autumn, and a new disclosure ruling has just reshaped the fight. The Competition Appeal Tribunal gave Google access to material that could carry “profound consequences” for a £1 billion claim, just two months before the case opens. Thousands of UK app developers and millions…
AstraZeneca (LON: AZN) Shares Plunge Up to 9% After Wainua Misses Primary Endpoint in Late-Stage Trial
AstraZeneca shares plunged as much as 9.55% on Thursday, July 9, 2026, after a major trial setback. The company’s heart drug Wainua failed to meet its primary endpoint in a Phase III study. That single announcement wiped out between £19 billion and £20 billion in market value. AstraZeneca’s market capitalization fell below £200 billion, though…
FTSE 100 Falls 0.49% as U.S.-Iran Tensions Escalate; AstraZeneca Slumps After Late-Stage Trial Failure
The FTSE 100 traded lower on Thursday, July 9, 2026, down roughly 0.5% during the morning session. AstraZeneca shares plunged as much as 9.55%, wiping out nearly £19 billion in market value. That single stock drove almost all of London’s underperformance versus other European indices. Germany’s DAX gained 0.4%, while France’s CAC 40 rose 0.45%…
ENB Stock Rallies as Q2 Earnings Loom, Energy Demand Surges—July 9
Enbridge (ENB.TO) trades near all-time highs ahead of Q2 2026 earnings July 31. Energy demand booming from LNG and data centres. Meyka rates ENB B+ with 3-year forecast of C$104.12.
Bitcoin Falls 3% to $61,480 as Trump Declares Iran Ceasefire ‘Over’
Bitcoin dropped more than 3% to $61,480 on July 8 after Trump declared the Iran ceasefire ended and threatened new strikes, rattling crypto and stock markets amid renewed geopolitical tension.